Accentia Biopharmaceuticals, Inc. (ABPI) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 16 PAGES: 36

More Info
									              Accentia Biopharmaceuticals, Inc. (ABPI) - Financial and Strategic
                                 SWOT Analysis Review
        Reference Code: GDPH66476FSA                                                                                           Publication Date: JAN 2013

          Suite 350, 324 South Hyde Park
                                                             Phone              +1 813 8642554                  Revenue          4 (million USD)
          Avenue
          Tampa, FL                                          Fax                +1 813 2586912                  Net Profit       -11.55 (million USD)
          33606                                              Website            www.accentia.net                Employees        54
                                                                                ABPI     [Over          The                      Pharmaceuticals           &
          United States                                      Exchange                                           Industry
                                                                                Counter]                                         Healthcare

       Company Overview
       Accentia Biopharmaceuticals, Inc. (Accentia) is a biotechnology company. It identifies, develops and commercializes patent-
       protected disruptive healthcare technologies for the treatment of chronic and life threatening diseases including the respiratory,
       autoimmune and cancer indications. The company’s key product portfolio consists of BiovaxID, for the treatment of indolent
       follicular Non–Hodgkin's lymphoma and other B–cell related blood cancers; Cyrevia, for the treatment of multiple sclerosis and
       other autoimmune diseases and; SinuNase, for the treatment of chronic sinusitis.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Accentia Biopharmaceuticals, Inc., SWOT Analysis
         Francis E. O'Donnell, Jr. Chairman                                           Strengths                              Weaknesses
         M.D.
                                                                                      Late Stage Products                    Weak Financial Performance
         Christopher C. Chapman, Director
         M.D.                                                                         Patent Portfolio                       Working Capital Deficit
         David M. Schubert                   Director
         Edmund C. King                      Director                                 Opportunities                          Threats
         William S. Poole                    Director
                                                                                      Changing Demographics                  Tightening of FDA’s Regulatory
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                                                                 Oversight
                                                                                      Focus on Key Therapeutic
       Share Data                                                                     Areas                                  Intense Competition
         Accentia Biopharmaceuticals, Inc.
        Share Price (USD) as on 15-Jan-                                  0.07        Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
        2013
        EPS (USD)                                                       -0.17
        Market Cap (million USD)                                            6
        Enterprise Value (million USD)                                     63
        Shares Outstanding (million)                                       90
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      May 15, 2012         Accentia Biopharma Reports Revenue Of
                                                                                                           $1.2m In Q2 Fiscal 2012
                                                                                      Feb 10, 2012         Accentia Biopharma Reports Revenue Of
                                                                                                           $1.2m In Q1 Fiscal 2012
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData




       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Accentia Biopharmaceuticals, Inc. (ABPI) - Financial and Strategic                                                             Reference Code: GDPH66476FSA
SWOT Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Accentia Biopharmaceuticals, Inc. - Key Facts................................................................................................................................... 5
       Accentia Biopharmaceuticals, Inc. - Key Employees.......................................................................................................................... 6
       Accentia Biopharmaceuticals, Inc. - Key Employee Biographies........................................................................................................ 7
       Accentia Biopharmaceuticals, Inc. - Major Products and Services ..................................................................................................... 8
       Accentia Biopharmaceuticals, Inc. - Pharmaceutical Pipeline Products Data..................................................................................... 9
          Accentia Biopharmaceuticals, Inc., Pipeline Products by Therapy Area ......................................................................................... 9
          Accentia Biopharmaceuticals, Inc., Pipeline Products by Development Phase ............................................................................ 10
       Accentia Biopharmaceuticals, Inc. - History ..................................................................................................................................... 12
       Accentia Biopharmaceuticals, Inc. - Company Statement ................................................................................................................ 14
       Accentia Biopharmaceuticals, Inc. - Locations And Subsidiaries ..................................................................................................... 16
          Head Office ................................................................................................................................................................................... 16
          Other Locations & Subsidiaries ..................................................................................................................................................... 16
       Section 2 – Company Analysis ......................................................................................................................................................... 17
       Accentia Biopharmaceuticals, Inc. - Business Description ............................................................................................................... 17
       Accentia Biopharmaceuticals, Inc. - Corporate Strategy .................................................................................................................. 18
       Accentia Biopharmaceuticals, Inc. - SWOT Analysis ....................................................................................................................... 19
          SWOT Analysis - Overview........................................................................................................................................................... 19
          Accentia Biopharmaceuticals, Inc. - Strengths.............................................................................................................................. 19
             Strength - Late Stage Products ................................................................................................................................................. 19
             Strength - Patent Portfolio ......................................................................................................................................................... 19
             Strength - Diversified Service Offerings .................................................................................................................................... 19
          Accentia Biopharmaceuticals, Inc. - Weaknesses ........................................................................................................................ 19
             Weakness - Weak Financial Performance ................................................................................................................................ 19
             Weakness - Working Capital Deficit .......................................................................................................................................... 20
          Accentia Biopharmaceuticals, Inc. - Opportunities........................................................................................................................ 20
             Opportunity - Changing Demographics ..................................................................................................................................... 20
             Opportunity - Focus on Key Therapeutic Areas ........................................................................................................................ 20
             Opportunity - Emerging Markets ............................................................................................................................................... 20
          Accentia Biopharmaceuticals, Inc. - Threats ................................................................................................................................. 21
             Threat - Tightening of FDA’s Regulatory Oversight ................................................................................................................... 21
             Threat - Intense Competition ..................................................................................................................................................... 21
             Threat - Uncertain R&D Outcomes ........................................................................................................................................... 21
       Accentia Biopharmaceuticals, Inc. - Key Competitors ...................................................................................................................... 22
       Section 3 – Company Financial Ratios ............................................................................................................................................. 23
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 23
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 23
       Performance Chart ........................................................................................................................................................................... 25
       Financial Performance...................................................................................................................................................................... 25
       Financial Ratios - Interim Ratios....................................................................................................................................................... 26
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 27
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 28


Accentia Biopharmaceuticals, Inc. (ABPI) - Financial and Strategic                                                                                             Reference Code: GDPH66476FSA
SWOT Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
          Accentia Biopharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ...................................... 28
          Accentia Biopharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 ...................................... 29
       Accentia Biopharmaceuticals, Inc., Recent Deals Summary ............................................................................................................ 30
       Section 5 – Company’s Recent Developments ................................................................................................................................ 31
          Accentia Biopharmaceuticals, Inc., Recent Developments ........................................................................................................... 31
             May 15, 2012: Accentia Biopharma Reports Revenue Of $1.2m In Q2 Fiscal 2012 ................................................................. 31
             Feb 10, 2012: Accentia Biopharma Reports Revenue Of $1.2m In Q1 Fiscal 2012.................................................................. 31
       Section 6 – Appendix ....................................................................................................................................................................... 32
          Methodology ................................................................................................................................................................................. 32
          Ratio Definitions ............................................................................................................................................................................ 32
          About GlobalData ......................................................................................................................................................................... 36
          Contact Us .................................................................................................................................................................................... 36
          Disclaimer ..................................................................................................................................................................................... 36




Accentia Biopharmaceuticals, Inc. (ABPI) - Financial and Strategic                                                                                             Reference Code: GDPH66476FSA
SWOT Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 3
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       List of Tables
       Accentia Biopharmaceuticals, Inc., Key Facts .................................................................................................................................... 5
       Accentia Biopharmaceuticals, Inc., Key Employees ........................................................................................................................... 6
       Accentia Biopharmaceuticals, Inc., Key 
								
To top